Ignite Creation Date:
2024-05-06 @ 1:05 PM
Last Modification Date:
2024-10-26 @ 1:08 PM
Study NCT ID:
NCT03929666
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-06
First Post:
2019-02-22
Brief Title:
A Safety and Efficacy Study of ZW25 Zanidatamab Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers Including Gastroesophageal Adenocarcinoma Biliary Tract Cancer and Colorectal Cancer
Sponsor:
Organization:
Jazz Pharmaceuticals